zoledronic acid teva pharma
teva b.v. - zoledronsýra - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - lyf til að meðhöndla beinsjúkdóma - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. meðferð gerðar voru á fyrirbyggjandi er sjúkdómur bein í fullorðnir.
treo citrus freyðitafla 500/50 mg
viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500/50 mg
treo freyðitafla 500 mg/50 mg
viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500 mg/50 mg
alendronat bluefish tafla 70 mg
bluefish pharmaceuticals ab - acidum alendronicum natríum - tafla - 70 mg
treo freyðitafla 50 mg/ 500 mg
viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 50 mg/ 500 mg
treo hindbær freyðitafla 500/50 mg
viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 500/50 mg
hjartamagnýl magasýruþolin tafla 75 mg
teva b.v.* - acidum acetylsalicylicum - magasýruþolin tafla - 75 mg
fucithalmic augndropar, dreifa 10 mg/g
amdipharm limited* - acidum fusidicum inn - augndropar, dreifa - 10 mg/g
fucidin krem 20 mg/g
leo pharma a/s* - acidum fusidicum inn - krem - 20 mg/g
alendronat teva tafla 70 mg
teva b.v.* - acidum alendronicum natríum - tafla - 70 mg